Approval Of New Drugs For Treatment Of Chronic Heart Failure


Posted December 19, 2018 by aleemtbrc

The global cardiovascular drugs market was valued at around $129 billion in 2017. North America was the largest region in the cardiovascular drugs market in 2017, accounting for nearly 40% market share.

 
The global cardiovascular drugs market, a part of the healthcare industry, declined at a compound annual growth rate (CAGR) of around -0.1% during the historic period. The healthcare industry showed a decline. The decline in the market is due to patent expiries of a major brands of cardiovascular drugs such as Lipitor, Plavi and others. Loss of patency has increased the market scope for generic versions of the drug with a huge difference in the prices.



In the forecast period, the global cardiovascular drugs market size is expected to be over $65 billion by 2021, growing at a CAGR of nearly 2%. This is expected due to the increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment. Furthermore, rising population, increase in dispensable income, and increasing per capita incomes are expected to drive the global cardiovascular drugs market in the future. 



Find TBRC’s report on the cardiovascular drugs market: https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2018



The Food and Drug Administration (FDA) in the USA has approved new drugs for treatment of chronic heart failure. Chronic heart failure is a cardiovascular disorder caused by an inadequate cardiac output (ability of the heart to pump blood)



Major companies in the cardiovascular drugs market, offering FDA technology include Merck & Co., Sanofi S.A., Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly And Company, Johnson & Johnson, AstraZeneca Plc., Abbott Laboratories Inc., Bayer AG.



Download a sample report: https://www.thebusinessresearchcompany.com/sample.aspx?id=271&type=smp



About The Business Research Company.



The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.



Contact Information.



The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Aleemuddin
Phone +442071930708
Business Address The Business Research Company,
www.thebusinessresearchcompany.com,
Country United Kingdom
Categories Business , Health
Last Updated December 19, 2018